REATA PHARMACEUTICALS INC-A (RETA) Stock Cash Flow
NASDAQ:RETA - Nasdaq - US75615P1030 - Common Stock - Currency: USD
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -87.62M | -311.90M | -297.39M | -247.75M | -290.17M | |||
| Depreciation Amortization | 1.13M | 1.13M | 1.20M | 1.14M | 930.00K | |||
| Change In Working Capital | 7.84M | 9.31M | -49.58M | -172.68M | 10.33M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 8.02M | 8.21M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | -169.69M | 97.19M | 110.06M | 96.96M | 27.76M | |||
| OPERATING CASH FLOW | -248.34M | -204.27M | -235.70M | -322.34M | -251.15M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.12M | -3.27M | -1.33M | -930.00K | -2.67M | |||
| Other Investing Activity | 60.54M | -341.89M | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | 59.42M | -345.16M | -1.33M | -930.00K | -2.67M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | -167.17M | 75.00M | |||
| Stock Issued/Repurchased | 18.43M | 1.49M | 9.14M | 644.67M | 506.01M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -410.00K | -650.00K | |||
| FINANCING CASH FLOW | 90.61M | 1.49M | 9.14M | 477.09M | 580.36M | |||
| CHANGE IN CASH | -98.31M | -547.95M | -227.89M | 153.82M | 326.54M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -248.34M | -204.27M | -235.70M | -322.34M | -251.15M | |||
| Capital Expenditure | -1.12M | -3.27M | -1.33M | -930.00K | -2.67M | |||
| FREE CASH FLOW | -249.46M | -207.54M | -237.03M | -323.27M | -253.82M | |||
All data in USD